Related Experiment Video
Updated: May 19, 2026
08:06
Merging Ion Concentration Polarization between Juxtaposed Ion Exchange Membranes to Block the Propagation of the Polarization Zone
Published on: February 23, 2017
Nanofluidic preconcentration device in a straight microchannel using ion concentration polarization
Sung Hee Ko1, Yong-Ak Song, Sung Jae Kim
1Department of Mechanical Engineering, Pohang University of Science and Technology, San 31, Hyojadong, Pohang, Gyeongbuk 790-784, Korea.
Lab on a Chip
|August 22, 2012
Summary
This study presents a novel straight microchannel nanofluidic device for protein concentration. The design simplifies previous methods, enhancing detection sensitivity for biomarkers like C-reactive protein (CRP) by over 500-fold.
Area of Science:
- Nanofluidics
- Biomarker Detection
- Microfluidic Devices
Background:
- Conventional protein concentration devices often involve complex multi-channel designs.
- There is a need for simplified, efficient methods for preconcentrating samples to improve detection sensitivity.
Purpose of the Study:
- To introduce a simple, straight microchannel design for a nanofluidic protein concentration device.
- To demonstrate the device's efficiency and applicability in enhancing biomarker detection.
Main Methods:
- A straight microchannel design integrating anode and cathode channels was developed.
- The device's performance was tested using various material combinations (PDMS-glass, silicon-PDMS).
- A surface-based immunoassay for C-reactive protein (CRP) detection was performed using the device.
Main Results:
- The straight microchannel design achieved most functions of conventional two-channel devices.
- Detection sensitivity for C-reactive protein (CRP) was enhanced over 500-fold compared to assays without preconcentration.
- Reversible sealing without plasma bonding was achieved using a PDMS-silicon device.
Conclusions:
- The developed straight microchannel nanofluidic device offers a simplified and effective approach for protein preconcentration.
- This technology significantly enhances immunoassay sensitivity, enabling more sensitive detection of clinically relevant biomarkers.
- The device's modular design and efficient preconcentration capabilities hold promise for point-of-care diagnostics.
